Li Ge (#452)
- $ 8 B
- Pharmaceuticals
- United States
- M
- 59 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Li Ge is the chairman and CEO of Wuxi Apptec, a provider of research and clinical trial services to biotech and pharmaceutical industries worldwide. Li is also the chairman of biopharma contract research and manufacturing firm WuXi Biologics. A subsidiary of WuXi Apptec broke ground on a 190-acre pharmaceutical campus in Delaware in 2022. Li holds a Ph.D. in organic chemistry from Columbia University. His wife and Wuxi Apptec cofounder Zhao Ning passed away in 2023, at age 56, after battling cancer for 20 years.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Li Ge’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Li Ge’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $8.0B
(May 4, 2026)
© Iconic Billionaires